Amesbury, MA, United States of America

John J Pelletier


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of John J Pelletier

Introduction

John J Pelletier is a notable inventor based in Amesbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 3 patents to his name, Pelletier's work has advanced the understanding and application of restriction endonucleases and methyltransferases.

Latest Patents

Pelletier's latest patents include a method for cloning and expressing BsmBI restriction endonuclease and BsmBI methylase in E. coli, as well as a method for purifying the BsmBI endonuclease. This invention relates to recombinant DNA that encodes the BsmBI restriction endonuclease and methyltransferase, facilitating their expression in host cells. Additionally, he has developed a method for cloning and expressing BstYI restriction endonuclease and BstYI methylase in E. coli, along with purification methods for these enzymes. These innovations are crucial for various applications in genetic engineering and molecular biology.

Career Highlights

Pelletier is currently associated with New England Biolabs, Inc., a leading company in the field of molecular biology. His work at this organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Shuang-Yong Xu and Huimin Kong. Their collaborative efforts have further enhanced the impact of their research in the biotechnology sector.

Conclusion

John J Pelletier's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…